(19)
(11) EP 1 201 241 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.10.2010 Bulletin 2010/43

(45) Mention of the grant of the patent:
22.09.2010 Bulletin 2010/38

(21) Application number: 01204692.6

(22) Date of filing: 12.03.1998
(51) International Patent Classification (IPC): 
A61K 31/47(2006.01)
A61K 31/245(2006.01)
A61P 23/00(2006.01)
A61P 29/00(2006.01)
 A61K 31/445(2006.01)
A61K 31/165(2006.01)
A61P 23/02(2006.01)

(54)

Compositions containing capsaicin or capsaicin analogues and an anesthetic

Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum

Compositions contenant de la capsaicine ou des analogues de capsaicine et un anesthésique

(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 13.03.1997 US 40697

(43) Date of publication of application:
02.05.2002 Bulletin 2002/18

(62) Application number of the earlier application in accordance with Art. 76 EPC:
98911614.0 / 0998288

(73) Proprietors:
  • Campbell, James N.
    Lutherville, MD 21093 (US)
  • Pappagallo, Marco
    New York, NY 10016 (US)
  • Meyer, Richard A.
    Waretown, NJ 08758 (US)

(72) Inventors:
  • Campbell, James N.
    Lutherville, MD 21093 (US)
  • Pappagallo, Marco
    New York, NY 10016 (US)
  • Meyer, Richard A.
    Waretown, NJ 08758 (US)

(74) Representative: Bassett, Richard Simon et al
Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD
Nottingham NG1 5DD (GB)


(56) References cited: : 
WO-A-96/40079
US-A- 4 997 853
 US-A- 4 313 958
US-A- 5 008 289
   
  • WINNING A J ET AL: "RESPIRATORY AND CARDIOVASCULAR EFFECTS OF CENTRAL AND PERIPHERAL INTRAVENOUS INJECTIONS OF CAPSAICIN IN MAN EVIDENCE FOR PULMONARY CHEMOSENSITIVITY" CLINICAL SCIENCE (LONDON), vol. 71, no. 5, 1986, pages 519-526, XP008023925 ISSN: 0143-5221
  • EPSTEIN J B ET AL: "TOPICAL APPLICATION OF CAPSAICIN FOR TREATMENT OF ORAL NEUROPATHIC PAIN AND TRIGEMINAL NEURALGIA" ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, MOSBY, ST LOUIS, MO, US, vol. 77, no. 2, February 1994 (1994-02), pages 135-140, XP008023376 ISSN: 0030-4220
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).